MAPK1 and non-small cell lung carcinoma: The RAS-RAF-MAPK ERK kinase (MEK)-ERK pathway is a major determinant in the control of diverse cellular processes such as proliferation, survival, differentiation and motility, which controls cell survival and proliferation in NSCLC [43].